ESPEROVAX SIGNS EXCLUSIVE LICENSING AGREEMENT WITH THE UNIVERSITY OF MICHIGAN FOR A NOVEL MANUFACTURING TECHNOLOGY FOR THE PRODUCTION OF VACCINES AND THERAPEUTICS
/PRNewswire/ -- Esperovax, a leading developer of oral vaccines, today announced it has signed a new, exclusive licensing agreement with Innovation Partners at...
United States Prnewswire Esperovax David Ohagan Stefan Koehler University Of Michigan Innovation Partners
Source: prnewswire.com